Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in 
Pre-liver HSC Development and Limitations of an In Vivo Approach.

Senserrich, Jordi; Batsivari, Antoniana; Rybtsov, Stanislav; Gordon-Keylock, Sabrina; Souilhol, Celine; Buchholz, Frank; Hills, David; Zhao, Suling; Medvinsky, Alexander

doi:10.1016/j.stemcr.2018.08.004

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in Pre-liver HSC Development and Limitations of an In Vivo Approach.

MPS-Authors

/cone/persons/resource/persons219042

Buchholz, Frank
Max Planck Institute for Molecular Cell Biology and Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Senserrich, J., Batsivari, A., Rybtsov, S., Gordon-Keylock, S., Souilhol, C., Buchholz, F., et al. (2018). Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in Pre-liver HSC Development and Limitations of an In Vivo Approach. Stem cell reports, 11(3), 784-794. doi:10.1016/j.stemcr.2018.08.004.

Cite as: https://hdl.handle.net/21.11116/0000-0003-F680-6

Abstract

Hematopoietic stem cells (HSCs) develop in the embryonic aorta-gonad-mesonephros (AGM) region and subsequently relocate to fetal liver. Runx1 transcription factor is essential for HSC development, but is largely dispensable for adult HSCs. Here, we studied tamoxifen-inducible Runx1 inactivation in vivo. Induction at pre-liver stages (up to embryonic day 10.5) reduced erythromyeloid progenitor numbers, but surprisingly did not block the appearance of Runx1-null HSCs in liver. By contrast, ex vivo analysis showed an absolute Runx1 dependency of HSC development in the AGM region. We found that, contrary to current beliefs, significant Cre-inducing tamoxifen activity persists in mouse blood for at least 72 hr after injection. This deferred recombination can hit healthy HSCs, which escaped early Runx1 ablation and result in appearance of Runx1-null HSCs in liver. Such extended recombination activity in vivo is a potential source of misinterpretation, particularly in analysis of dynamic developmental processes during embryogenesis.